InspireMD, Inc. (NSPR)
1.70
+0.08
(+4.94%)
USD |
NASDAQ |
Jan 22, 13:56
InspireMD Research and Development Expense (Quarterly): 3.635M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Intuitive Surgical, Inc. | 329.40M |
| 908 Devices, Inc. | 3.378M |
| Perspective Therapeutics, Inc. | 19.56M |
| InfuSystem Holdings, Inc. | -- |
| Xtant Medical Holdings, Inc. | 0.634M |